HIA
TEVA icon

Harbor Investment Advisory’s Teva Pharmaceuticals TEVA Stock Holding History

Harbor Investment Advisory’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$34 Hold
1
– – ﹤0.01% 1305
2026
Q1 		$30 Hold
1
– – ﹤0.01% 1224
2025
Q4 		$31 Hold
1
– – ﹤0.01% 1218
2025
Q3 		$20 Hold
1
– – ﹤0.01% 1171
2025
Q2 		$17 Hold
1
– – ﹤0.01% 1165
2025
Q1 		$15 Hold
1
– – ﹤0.01% 1169
2024
Q4 		$22 Hold
1
– – ﹤0.01% 1141
2024
Q3 		$18 Hold
1
– – ﹤0.01% 1145
2024
Q2 		$16 Sell
1
-10
-91% -$154 ﹤0.01% 1297
2024
Q1 		$155 Buy
11
+10
+1,000% +$126 ﹤0.01% 1302
2023
Q4 		$10 Hold
1
– – ﹤0.01% 1153
2023
Q3 		$10 Buy
+1
New +$9 ﹤0.01% 1178

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Harbor Investment Advisory's TEVA Position: Q2 2026 in Review

Harbor Investment Advisory held its Teva Pharmaceuticals (TEVA) position steady in Q2 2026 at 1 share worth $34. The position accounts for ﹤0.01% of the portfolio, ranked #1305.

Harbor Investment Advisory first reported a position in TEVA in Q3 2023 and has held it in 12 quarters since. The position peaked at $155 in Q1 2024. 675 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Harbor Investment Advisory held 1 share of Teva Pharmaceuticals worth $34 as of Q2 2026.
  • Harbor Investment Advisory left its Teva Pharmaceuticals share count unchanged in Q2 2026.
  • Teva Pharmaceuticals made up ﹤0.01% of Harbor Investment Advisory's portfolio in Q2 2026, its #1305 holding.
  • Harbor Investment Advisory first reported a position in Teva Pharmaceuticals in Q3 2023 and has held it in 12 quarters since.
  • Harbor Investment Advisory's Teva Pharmaceuticals position peaked at $155 in Q1 2024.
  • 675 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.